Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010, 154(3):257-260 | DOI: 10.5507/bp.2010.039
SKIN CANCER INCIDENCE IN RENAL TRANSPLANT RECIPIENTS – A SINGLE CENTER STUDY
- a 2nd Department of Surgery, University Hospital Olomouc, Czech Republic
- b Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
- c Department of Plastic and Reconstructive Surgery, University Hospital Olomouc
- d 3rd Department of Internal Medicine, University Hospital Olomouc
Aims: To provide the first single-center study of a Czech renal transplant program that compares skin cancer risk estimates to the general population.
Methods: We studied a total of 603 patients undergoing renal transplantation at the University Hospital Olomouc Transplant Center between January 1984 and December 2009. The mean time of follow-up was 5.5 years. Three patients were excluded for skin cancer diagnosis before transplant. The cohort was linked with the National Cancer Registry of the Czech Republic. For non-melanoma skin cancer (NMSC), the observed number of cancers were compared to the expected numbers of NMSC based on national cancer incidence rates stratified by age. The standartized incidence ratio (SIR) was calculated as observed-to-expected ratios.
Results: We found a total of 127 cases of skin cancers in 55 patients. 52/55 (94.5%) were patients with non-melanoma skin cancers, 2/55 (3.6%) patients had malignant melanoma, and we uncovered one case of merkel cell carcinoma of the skin (1.8%). There were no cases of Kaposi's sarcoma, cutaneous lymphoma or malignant fibrous histiocytoma. For NMSC, the overall SIR was 7.39 (95% confidence interval 5.52-9.70). Thus, skin cancer was the most common malignant condition, representing 64.1% of all malignant tumours detected in study population.
Conclusion: We confirmed that skin cancer is a major complication in renal transplant recipients. Therefore it is important to increase the intensity of surveillence for these lesions in transplant patients.
Keywords: Cancer risk, Transplantation, Skin cancer, Immunosuppression
Received: July 20, 2010; Accepted: September 3, 2010; Published: September 1, 2010 Show citation
References
- Walder B, Robertson M, Jeremy D. Skin cancer and immunosuppression. Lancet 1971;2:12823.
Go to original source...
Go to PubMed...
- Bouwes-Bavinck JN, De Boer A, Vermeer BJ, Hartevelt MM, van der Woude FJ, Claas FH, et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129:2429.
Go to original source...
Go to PubMed...
- Bouwes-Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, OSullivan B, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation 1996; 61:71521.
Go to original source...
Go to PubMed...
- Ramsay H, Fryer A, Hawley C, Smith AG, Nicol DL, Harden PN. Non-melanoma skin cancer risk in the Queensland transplant population. Br J Dermatol 2002; 147: 9506.
Go to original source...
Go to PubMed...
- Kyllönen L, Salmela K, Pukkala E. Cancer incidence in kidneytransplanted population. Transpl Int 2000; 13:3948.
Go to original source...
- Adami J, Gäbel H, Lindelö B, Ekströ K, Rydh1 B, Glimelius B. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89:12217.
Go to original source...
Go to PubMed...
- Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after transplantation in The Netherlands. Transplantation 1990; 49:5069.
Go to original source...
Go to PubMed...
- Hoshida Y, Tsukuma H, Yasunaga Y, Xu N, Fujita MQ, Satoh T, Ichikawa Y, et al. Cancer risk after renal transplantation in Japan. Int J Cancer 1997; 71:51720.
Go to original source...
Go to PubMed...
- Ju MK, Joo DJ, Kim SJ, Huh KH, Kim MS, Jeon KO, et al. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single centrer experience. Transpl Int 2009; 22:64453.
Go to original source...
Go to PubMed...
- Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents, Vol. VI, IARC Scientific Publication 120, IARC, Lyon 1992.
- Grulich AE, van Leewen MT, Falster MO,Vajdic CM. Incidence of cancers in people with HIV/AIDS compared to immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370:5967.
Go to original source...
Go to PubMed...
- Lindelöf B, Sigurgeirsson B, Gäbel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143:5139.
Go to original source...
Go to PubMed...
- Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154:498504.
Go to original source...
Go to PubMed...
- Ferrandiz C, Fuente MJ, Ribera M, Bielsa I, Fernández MT, Lauzurica R, et al. Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995; 33:5906.
Go to original source...
Go to PubMed...
- Hepburn DJ, Divakar D, Bailey RR, Macdonald KJ. Cutaneous manifestations of renal transplantation in a New Zealand population. N Z Med J 1994; 107:4979.
- Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. [see comments] Nature 1999; 397:5304.
Go to original source...
Go to PubMed...
- Moore DE, Sik RH, Bilski P, Chignell CF, Reszka KJ. Photochemical sensitization by azathioprine and its metabolites. Part 3. A direct EPR and spin-trapping study of light-induced free radicals from 6-mercaptopurine and its oxidation products. Photochem Photobiol 1994; 60:57481.
Go to original source...
Go to PubMed...
- Kelly GE, Meikle W, Sheil AG. Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice. Transplantation 1987; 44:42934.
Go to original source...
Go to PubMed...
- Kovach BT, Stasko T. Skin cancer after transplantation. Transplantation Rev 2009; 23:178189.
Go to original source...
Go to PubMed...
- Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002; 8:12835.
Go to original source...
Go to PubMed...
- Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40:17786.
Go to original source...
Go to PubMed...
- Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, et al. Cancer risk after renal transplantation in the Nordic countries 19641986. Int J Cancer 1995; 60:1839.
Go to original source...
Go to PubMed...
- Euvrard S, Kanitakis J, Claudy A. Neoplastic skin diseases in organ transplant recipients. Am J Cancer 2002; 1:10920.
Go to original source...
- Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996; 61:2748.
Go to original source...
Go to PubMed...
- Koljonen V, Kukko H, Tukianen E, Böhling T, Sankila R, Pukkala E, et al. Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol Dial Transplant 2009; 24:32315.
Go to original source...
Go to PubMed...
- Penn I. Kaposis sarcoma in transplant recipients. Transplantation 1997; 64:66973.
Go to original source...
Go to PubMed...